Industry news, page-422

hey @comincon what are your thoughts on the psychedelics business producing a recurring revenue stream? We know our CBD drugs will continue to have customers coming back as the medication requires to be taken regularly in order to continue receiving the health benefits.

My main concern with psychedelics is purely the long term profitability. I have no doubt there are some amazing health benefits but I do question whether we'll have those repeat users like we do with our CBD candidates. I assume the BOD will want to create something similar with our psychedelics arm where regular sessions are required to experience the full benefit rather than coming in for a couple of doses and then no longer requiring the medicine.